azenosertib
zentalis pharma
['azenosertib', 'zentalisp']
today, will present preclinical data demonstrating that azenosertib can achieve pharmacologically-relevant intracerebral free-drug concentrations &amp; that pharmacodynamic activity is observed in a preclinical glioblastoma model. more: #aacr23 
Developing small molecule #therapeutics targeting fundamental biological pathways of #cancers